Literature DB >> 16919603

The coding sequence mediates induction of 5-lipoxygenase expression by Smads3/4.

Sabine Seuter1, Bernd L Sorg, Dieter Steinhilber.   

Abstract

5-Lipoxygenase (5-LO) expression is strongly induced by transforming growth factor-beta (TGFbeta) and 1alpha,25-dihydroxyvitamin D(3) in Mono Mac 6 cells. Since Smads have been described as downstream effectors of TGFbeta, we have investigated the role of the TGFbeta/Smad signalling system in the regulation of 5-LO gene expression. The rapid induction of 5-LO mRNA, determined with real-time quantitative RT-PCR, suggests that 5-LO is a primary TGFbeta target gene. In reporter gene assays with plasmids containing the 5-LO promoter plus different parts of the gene, Smads3/4 mediate a prominent upregulation of reporter activity that strongly depends on the coding sequence and to a lesser extent on the 3'-UTR and introns J-M. Deletion studies revealed the most profound decrease of inducibility by Smads3/4 when exons 10-14 are deleted. Sequence analysis and deletion studies indicate the existence of up to four Smad binding elements and at least one TGFbeta responsive element far downstream of the transcriptional start site.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919603     DOI: 10.1016/j.bbrc.2006.08.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.

Authors:  Wen Tian; Xinguo Jiang; Yon K Sung; Eric Shuffle; Ting-Hsuan Wu; Peter N Kao; Allen B Tu; Peter Dorfmüller; Aiqin Cao; Lingli Wang; Gongyong Peng; Yesl Kim; Patrick Zhang; James Chappell; Shravani Pasupneti; Petra Dahms; Peter Maguire; Hassan Chaib; Roham Zamanian; Marc Peters-Golden; Michael P Snyder; Norbert F Voelkel; Marc Humbert; Marlene Rabinovitch; Mark R Nicolls
Journal:  Circulation       Date:  2019-08-29       Impact factor: 29.690

2.  5-Lipoxygenase: mechanisms of regulation.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

3.  Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase-activating protein/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes.

Authors:  Shu-Huang Chen; Hassan Fahmi; Qin Shi; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2010-02-09       Impact factor: 5.156

4.  Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1.

Authors:  Xue-Qin Huang; Xia-Yan Zhang; Xiao-Rong Wang; Shu-Ying Yu; San-Hua Fang; Yun-Bi Lu; Wei-Ping Zhang; Er-Qing Wei
Journal:  J Neuroinflammation       Date:  2012-06-26       Impact factor: 8.322

5.  Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.

Authors:  Laura Pufahl; Careen Katryniok; Nicole Schnur; Bernd L Sorg; Julia Metzner; Manuel Grez; Dieter Steinhilber
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

6.  Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL.

Authors:  K Ahmad; C Katryniok; B Scholz; J Merkens; D Löscher; R Marschalek; D Steinhilber
Journal:  Oncogenesis       Date:  2014-11-17       Impact factor: 7.485

7.  CD69 is a TGF-β/1α,25-dihydroxyvitamin D3 target gene in monocytes.

Authors:  Thea K Wöbke; Andreas von Knethen; Dieter Steinhilber; Bernd L Sorg
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

8.  Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia.

Authors:  Shachar Raz; Michal Stark; Yehuda G Assaraf
Journal:  Oncotarget       Date:  2014-10-15

9.  AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.

Authors:  Khalil Ahmad; Bastian Scholz; Ricardo Capelo; Ilona Schweighöfer; Astrid Stefanie Kahnt; Rolf Marschalek; Dieter Steinhilber
Journal:  Oncotarget       Date:  2015-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.